The LEAN Study 2, sponsored by Yale University, investigates the efficacy and cost-effectiveness of a structured weight loss program versus usual care in breast cancer survivors. Given the rising prevalence of obesity and its association with poorer outcomes in breast cancer, this study addresses a significant unmet need in survivorship care. The findings could inform clinical guidelines and potentially lead to the development of commercial weight management programs tailored for this demographic. The market for obesity management solutions is substantial, with increasing demand for evidence-based interventions. Competitive implications include positioning against existing weight loss programs and potential partnerships with healthcare providers focused on cancer survivorship.